Target intelligence / Profile preview

Streptococcus mutans ADP-glucose pyrophosphorylase (ADP-Glc PPase)

Target
ADP-Glc PPase
Molecular classification
Enzyme, Transferase, Nucleotidyltransferase
01

Overview

Streptococcus mutans ADP-glucose pyrophosphorylase (ADP-Glc PPase) is a key regulatory enzyme in the biosynthesis of intracellular polysaccharides (IPS), which are glycogen-like polymers [1, 15]. This enzyme, encoded by the glgC and glgD genes, catalyzes the conversion of ATP and glucose-1-phosphate into ADP-glucose and inorganic pyrophosphate [1, 19]. In S. mutans, IPS serves as a critical energy reserve that the bacterium utilizes during periods of sugar starvation to produce lactic acid [1, 27]. This prolonged acid production leads to the demineralization of tooth enamel, making ADP-Glc PPase a significant virulence factor in the development of dental caries [8, 20]. Because this enzyme is absent in humans and plays a vital role in the cariogenic potential of the pathogen, it is considered a promising therapeutic target [21]. Compounds such as monofluorophosphate (MFP), a common additive in dental care products, have been shown to inhibit this enzyme, thereby reducing IPS accumulation and the subsequent risk of tooth decay [20, 22].

Other names
Glucose-1-phosphate adenylyltransferaseATP:alpha-D-glucose-1-phosphate adenylyltransferaseGlgCGlgD
02

Mechanism of action

Inhibition of ADP-glucose synthesis, leading to reduced intracellular polysaccharide (IPS) accumulation and decreased acid production.

03

Biological functions

Glycogen biosynthesisCarbohydrate metabolismEnergy storageVirulence
04

Disease associations

Dental cariesInfection
05

Safety considerations

Selectivity for the oral microbiomeMinimal host toxicity due to absence of the enzyme in humans
06

Interacting drugs

Monofluorophosphate

Beyond the preview

Go deeper on Streptococcus mutans ADP-glucose pyrophosphorylase (ADP-Glc PPase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus mutans ADP-glucose pyrophosphorylase (ADP-Glc PPase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call